CHAPEL HILL, N.C., Jan. 26, 2018 /PRNewswire/ — Pharmaceutical companies that have launched a new oncology product often pursue a second indication for the same product. The prevalent thinking across the industry is that a company can leverage cost savings for the second launch by…
